★★★★★
"Weekly injections made portion control effortless."
Geoff
Verified Customers
+
+
.7★
Tirzepatide is an injectable prescription weight-loss medication. It is used to help control blood sugar levels in adults with type 2 diabetes. It also suppresses appetite and food cravings, which can lead to significant weight loss.
Tirzepatide works by mimicking the action of hormones called GLP-1 and GIP. It stimulates insulin release from the pancreas, reduces glucagon secretion, slows down gastric emptying, and promotes a feeling of fullness. These actions help lower blood sugar levels and promote weight loss.
Tirzepatide has shown significant benefits in controlling blood sugar levels, reducing body weight, and lowering cardiovascular risks in people with type 2 diabetes.
Tirzepatide is administered as a subcutaneous injection (under the skin) once a week. The injection can be self-administered or given by a healthcare professional.
The most common side effects of tirzepatide include gastrointestinal symptoms such as:
These side effects are usually mild to moderate and tend to improve over time.
Combining medications or interventions for weight loss purposes should be discussed with a healthcare professional. They can provide guidance on potential interactions, contraindications, and the most appropriate approach based on your individual circumstances.
Tirzepatide has been shown to improve blood sugar control within weeks of starting treatment. Maximum weight-loss benefits are typically seen after several months of use.
Tirzepatide can be used alone or in combination with other antidiabetic medications, such as metformin or insulin, depending on individual needs. However, a healthcare professional should determine specific combinations. For example, if too high an insulin dose is used with tirzepatide, it could cause a dangerous decrease in blood sugar (hypoglycemia).
Tirzepatide is not a cure for diabetes. It is a medication that helps manage blood sugar levels and provides additional benefits for people with type 2 diabetes. Diabetes management involves a comprehensive approach, including lifestyle modifications and ongoing medical care.
The retail cost ranges from $900 to $1500 per month, based on the prescribed dose. Savings cards and copay assistance programs are available.
No. People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2) should not take tirzepatide.
Do not take tirzepatide if you are pregnant, trying to conceive, or if you have a history of pancreatitis.
Important Medication Info: FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™. This website is not affiliated with, endorsed by, or connected in any way to these companies or their products.
We do not supply these FDA-approved branded medications. Instead, we offer compounded versions when medically appropriate and legally permissible. These compounded medications are prepared by licensed pharmacies in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act.
Compounded drugs are not FDA-approved. This means they do not undergo FDA premarket review for safety, efficacy, or manufacturing quality. Compounded medications may play an important role for patients whose needs cannot be met by commercially available drugs, but they have not been demonstrated to the FDA to be safe or effective for any particular use.
Important Medication Info: FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™. This website is not affiliated with, endorsed by, or connected in any way to these companies or their products.
We do not supply these FDA-approved branded medications. Instead, we offer compounded versions when medically appropriate and legally permissible. These compounded medications are prepared by licensed pharmacies in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act.
Compounded drugs are not FDA-approved. This means they do not undergo FDA premarket review for safety, efficacy, or manufacturing quality. Compounded medications may play an important role for patients whose needs cannot be met by commercially available drugs, but they have not been demonstrated to the FDA to be safe or effective for any particular use.
Safety Info: Compounded Tirzepatide may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2. Prescription medications available only if prescribed by the healthcare provider after an online consultation. This is a compounded medication.